Authors: Schellekens, H Geelen, G Meritet, JF Maury, C Tovey, MG

Citation: H. Schellekens et al., Oromucosal interferon therapy: Relationship between antiviral activity andviral load, J INTERF CY, 21(8), 2001, pp. 575-581

Authors: Sonnenfeld, G Tovey, M Schellekens, H Kinney, KS Belay, T Morton, DS Austin, CE Reitman, M Fong, TAT Vaughan, HS

Citation: G. Sonnenfeld et al., Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murineencephalomyocarditis virus, J INTERF CY, 21(7), 2001, pp. 539-545

Authors: Schellekens, H Schulman, MB

Citation: H. Schellekens et Mb. Schulman, Contact temperature and erosion in high-current diffuse vacuum arcs on axial magnetic field contacts, IEEE PLAS S, 29(3), 2001, pp. 452-461

Authors: Schulman, MB Schellekens, H

Citation: Mb. Schulman et H. Schellekens, Visualization and characterization of high-current diffuse vacuum arcs on axial magnetic field contacts (vol 27, pg 443, 2000), IEEE PLAS S, 28(3), 2000, pp. 1050-1050

Authors: Schulman, MB Schellekens, H

Citation: Mb. Schulman et H. Schellekens, Visualization and characterization of high-current diffuse vacuum arcs on axial magnetic field contacts, IEEE PLAS S, 28(2), 2000, pp. 443-452

Authors: Schellekens, H

Citation: H. Schellekens, Health risks of genetically modified foods, LANCET, 354(9172), 1999, pp. 70-71